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Pain patterns in patients with polycystic kidney disease.
Background. Pain is a common problem in patients with poly-
cystic kidney disease (PKD), but patterns have not been charac-
terized as to frequency and severity. Physicians should be aware
of pain problems so an approach to chronic pain management
can be pursued.
Methods. One hundred seventy-one completed question-
naires out of 300 distributed to PKD patients whose renal func-
tion ranged from normal to end-stage renal disease (ESRD)
were analyzed. Age at diagnosis of PKD was documented, and
patients noted how the diagnosis was made. Location, severity,
and frequency of pain were characterized. The Visual Analogue
Scale (VAS) was used to measure pain intensity.
Results. There were 94 females and 77 male respondents, with
a mean age of 47.4 years. Initial diagnosis of PKD occurred
at a mean age of 31.6 years. Caucasians comprised 92.2% of
the respondents. Patients’ symptoms, a family history of PKD,
and discovery of PKD during evaluation for hypertension or
hematuria were the most frequent factors that led to the diag-
nosis. Order of frequency of pain was: low back pain, abdominal
pain, headache, chest pain, and leg pain. Severity of pain, doc-
umented by the VAS intensity, was 4 to 5/10 in the majority of
patients.
Conclusion. Pain, which can be diffuse, is the most frequent
symptom that led to the diagnosis of PKD in patients who
responded to this questionnaire, and occurs with greater fre-
quency than generally appreciated. Physicians need to obtain
a detailed history about pain in their PKD population so as to
allow an approach to pain management.
Autosomal-dominant polycystic kidney disease
(ADPKD) is an important cause of medical morbid-
ity in the United States. All forms of cystic disease
affect almost one million persons. Both ADPKD and
autosomal-recessive polycystic kidney disease (ARPKD)
are the most common types of cystic disease [1], and
account for 7.4% of prevalent dialysis patients and
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9.5% of prevalent transplantation patients. The incident
rate for cystic disease as the cause for end-stage renal
disease (ESRD) is less than 5% [2]. Half of the affected
individuals reach ESRD at a mean age of 53 years
[3]. PKD has aroused interest over the recent years as
geneticists search for ADPKD and ARPKD genes and
their protein products, while cell biologists investigate
the pathophysiology of cyst formation.
Pain afflicts approximately 60% of patients with poly-
cystic kidney disease (PKD) [4] and often leads to the
diagnosis. Management of this unpleasant sensory expe-
rience frequently causes frustration for the caregivers.
Because of the many etiologies of pain, both diagnosis
and management can be challenging in these patients.
No extensive literature exists which describes the pain
patterns in this population.
During the prolonged course of the disease, PKD is
characterized by the formation and progressive enlarge-
ment of renal cysts that often lead, directly and indirectly,
to symptoms of acute and chronic pain. Upon clinical pre-
sentation, approximately 30% of those with PKD have
accompanying polycystic liver disease [5].
Severe persistent abdominal and flank pain affects pa-
tients afflicted with ADPKD and is a source of great
frustration for patients and treating physicians [6, 7].
The often-employed physician response of prescribing,
as a first step, a nonsteroidal anti-inflammatory agent
(NSAID) or cyclooxygenase-2 (COX-2) inhibitors can
be accompanied by gastrointestinal and renal adverse ef-
fects. This study will take a thorough look at the pain
patterns among patients with PKD in the attempt to de-
cipher the cause for the various presentations. An un-
derstanding of the factors that cause frequent and severe
suffering in this population hopefully can lead to targeted
treatments.
METHODS
Three hundred patients with PKD were given a survey
questionnaire (the 8-page questionnaire is condensed and
appears as an Appendix). This population was identified
from the private practice of one of the authors (TIS) and
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in patients attending an annual Polycystic Kidney Disease
Foundation (PKDF) meeting. Approximately one third
of the respondents came from the private practice set-
ting, and two thirds came from the attendees at the PKD
meeting. No difference could be discerned between the
two groups of respondents with regard to level of kidney
function, character of pain, pattern of presentation, or
socioeconomic status. Both groups represented the spec-
trum of kidney function, from normal function to ESRD.
No patient-identifying characteristics were on the
questionnaire during independent analysis designed to
prevent bias. The purpose of the questionnaire was to
note the pain patterns (i.e., mode of presentation, fre-
quency, severity) and modalities of therapy employed
by both patients and their physicians in a representa-
tive population of patients with PKD who were not in
acute crisis pain at the time of responding. The reported
pain symptoms ranged from none to life-altering severe
chronic pain in this surveyed population whose kidney
function varied between normal and ESRD (both dialy-
sis and transplantation).
One hundred eighty-four responded by answering
most questions, but the 171 patients with complete in-
formation were included in the study. The questionnaire
inquired about details of intensity, duration, and referral
of the most common types of pain experienced by these
patients with PKD. Noted in order of frequency were low
back pain, abdominal pain, headache, chest pain, and leg
pain.
The frequently used and validated 100-mm Visual Ana-
logue Scale (VAS) is a clinical scale used to measure pain
intensity and was employed in the questionnaire. Patients
use a 10-cm/100-mm horizontal line to mark and rate their
pain from a score of 0 on the far left, representing no pain,
to a score of 10 (100) on the extreme right, representing
worst pain possible. It provides an accurate descriptor for
a patient’s perceived level of pain and is a highly repro-
ducible measure of pain intensity [8].
RESULTS
Background
There were 94 females (55%) and 77 males (45%) in-
cluded in this study. Ages ranged from 10 years to 79 years,
and the mean age of the respondent was 47.4 years. Mean
age at their initial diagnosis of PKD was 31.6 years old.
Caucasian subjects dominated the group with a 92.2%
prevalence. African Americans (1.8%), Asians (2.3%),
and Hispanics (3.5%) were the remaining groups. Three
subjects left blank their ethnic background.
The socioeconomic status was perceived to be similar
between the private practice and the PKDF attendees
who responded to the questionnaire. However, socioeco-
nomic status was not specifically queried and, therefore,
detailed correlations between such status and pain char-
acteristics cannot be made.
How the diagnosis of PKD was made
The most common factor leading to the diagnosis
of PKD was the patient’s symptoms. Symptoms led to
the physician investigation and ultimate diagnosis in
37.4% of queried patients (see below for details about
symptoms).
This patient population may have known about a fam-
ily history of PKD, but did not equate their symptoms as
due to PKD at the time of initial presentation to the physi-
cian. It is important to note that this group is distinct from
those who sought evaluation because of a family history
(see below).
A positive family history of PKD was the next most
common theme that led to the diagnosis. A percentage of
patients (36.2%) reported that the diagnosis of PKD was
made during evaluation prompted by a positive family
history. Incidentally, 20.5% of respondents denied any
known family history of the disease.
There was 34.5% who were diagnosed during evalua-
tion of hypertension or asymptomatic microscopic hema-
turia. All sources of presentation (pain, family history,
findings during evaluation) that led to a diagnosis of PKD
exceeded 100% (108.1%). For example, pain was the fac-
tor that prompted a physician evaluation, and the patient
was aware of a family history of ADPKD. However, the
patient drew a correlation between symptoms and family
history only after the diagnosis was confirmed.
There appears to be no correlation between the level of
kidney function and pattern of presentation or intensity
of pain when the responses of patients from the private
practice setting were examined and their lab data noted.
Patients with normal kidney function had pain patterns
similar to those with advanced renal disease. Kidney func-
tion test results were not available from the respondents
who attended the PKDF meeting.
Back pain, noted by 17.5% of patients, was the most
common symptom reported in the questionnaire that ac-
tually led to the diagnosis. Hematuria was the second
most common reason that led to the diagnosis of PKD, re-
ported by 16.4%. When hematuria was present, 32.2% of
respondents reported an association with back or abdom-
inal pain. As stated earlier, evaluation for hematuria was
pursued by patients independent of their known family
history. Patients may have been in denial about the fam-
ily history or simply were unaware that hematuria was
related to PKD. This important information will never
be known from the questionnaire as designed. Only after
a diagnosis of PKD was made did patients report a family
history in many cases.
Bajwa et al: Pain patterns in patients with PKD 1563
100
80
60
40
20
0
%
 o
f P
a
tie
nt
s
Symptoms
Family history
Incidental finding
37.4 36.2 34.5
Fig. 1. Reasons leading to the initial diagnosis of polycystic kidney dis-
ease (PKD). The percentage of PKD patients who had varying reasons
that led to the diagnosis of PKD. Symptoms are described in the text.
There were also 16.4% of patients who reported nonde-
script abdominal pain that led directly to their diagnosis
(Fig. 1).
A frequent history of either low back pain or abdom-
inal pain was reported by 42.2% of patients before their
diagnosis, but it did not lead to the initial diagnosis. How-
ever, from the questionnaire, it is not possible to unequiv-
ocally state that these symptoms were related to PKD.
When pain does occur, the majority (70.4%) had more
than one source of pain (back pain, abdominal pain, leg
pain, headache, or chest pain), while 17.9% had only one
focus of pain. Pain patterns are described in greater detail
below.
PKD diagnosed during evaluation for a noted problem
Almost one third of the time in this surveyed popu-
lation, the diagnosis of PKD was made during an eval-
uation for a finding noted by the referring physician.
The most detailed information is obtained from those
respondents in the private practice setting. A finding of
PKD was pursuant to an evaluation for resistant hyper-
tension or asymptomatic microscopic hematuria (without
abdominal or back pain). Radiologic findings confirming
the presence of PKD precipitated nephrology consulta-
tion, or the ultrasound or abdominal CT scan results were
noted by the nephrologist during workup for the present-
ing problem. Both those with a family history of PKD
(but not reported by patient before evaluation) and those
characterized as spontaneous mutations (description be-
low defines this term), were included in this group of
“diagnosis made without pain.” Infrequently gross hema-
turia, without accompanying pain, was the presenting sign
that led to the diagnosis. The number of patients without
a noted family history of PKD who presented with re-
sistant hypertension or symptomatic hematuria was too
small to draw conclusions about their clinical presenta-
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Fig. 2. Primary location of chronic pain after the diagnosis of polycystic
kidney disease (PKD) was established. Pain patterns in the diagnosed
PKD population frequently involve more than one area equally in a
single patient. Hence, the total percentage exceeds 100%; in this survey
it is 190%.
tion as compared to presenting manifestations in those
with a family history of PKD.
Pain patterns
Out of the total pool of 171 patients, 40.9% reported
treating their pain before the diagnosis of PKD. Of these,
45.7% used self-prescribed medication, while 54.3% used
nonpharmacologic methods. After PKD was diagnosed,
pain was reported as occurring with greater frequency
during the course of their disease than before the di-
agnosis. During the course of their definitive diagno-
sis, 62.0% of patients reported primarily chronic back
pain, and 49.7% had abdominal pain. Additional pain
patterns that include radiculopathy, chronic headaches,
and chest pain are characterized in Figure 2. Inter-
estingly, when the patients were asked whether they
thought their pains were related to their diagnosis of
PKD, only 9.4% responded in the affirmative; 53.8%
were not sure, and 36.8% did not believe their pains were
related.
Low back pain
Low back pain (71.3%) was the most common discom-
fort reported by patients with PKD during the course of
their disease. Figure 3 notes the frequency of these pain
patterns, which range from continuous to less than once
a month.
The VAS intensity in patients who reported low back
pain was distributed almost equally from mild to severe
and is listed in Figure 4. A percentage of the queried pop-
ulation (32.2%) noted taking medication for their low
back pain, with 25.7% using analgesics (ranging from ac-
etaminophen to codeine). Nonpharmacologic maneuvers
included 9.4% of patients using ice and 26.9% using heat
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Fig. 3. Frequency of low back pain symptoms. When pain was noted,
71.3% of the patients reported it to be low back pain. Over time, the
frequency of back pain increased in many subjects.
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Fig. 4. Visual Analogue Scale score in patients with low back pain. The
majority of the scores ranged between 2 and 8, with 37.7% of responders
being either 4 or 5/10.
for their low back pain. Surgery was reported in 5.8% for
their back pain.
Abdominal pain
Abdominal pain is the second most common pain pat-
tern in patients with PKD. There were 61.4% of the re-
spondents who reported recurring abdominal pain over
the years of their disease. Patients described their ab-
dominal pain as dull (49.5%), uncomfortable fullness
(42.7%), stabbing (40.4%), and cramping (33.0%). From
the response, more than one type of pain was reported by
the affected patients. Figure 5 notes the character of the
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Fig. 5. Descriptions of the type of abdominal pain. As with other pain
patterns, the quality of the pain pattern changed over time. Therefore,
patients reported more than one type of abdominal pain.
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Fig. 6. Visual Analogue Scale score in patients with abdominal pain.
The majority of patients scored their pain between 2 and 8, with the
most common scores being between 4 and 7 (55.2%).
pain pattern and the frequency of nausea and vomiting.
Severity of pain, using the VAS, generally was character-
ized between 3 to 8/10 in a bell-shaped curve distribution
(Fig. 6).
Frequency of abdominal pain ranged from constant to
less than once per month (Fig. 7). Abdominal pain was
treated in 17.5% of these patients using acetaminophen
or codeine, while 20.5% used heat and 2.9% used ice.
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Fig. 7. Frequency of abdominal pain. Almost 27% of patients reported
abdominal pain as daily or constant, while 20.8% reported it as occurring
less than once per month.
Radicular pain
There was 26.9% of the responding patient pool who
reported back pain radiating to the hips or legs. Of these
patients, 70.5% characterized their experience as either a
constant shooting pain, daily pain, or once a week discom-
fort. An almost equal distribution (22.7%, 20.5%, 27.3%,
respectively) of the three patterns was noted. Radicu-
lopathy symptoms uncommonly occurred once a month
(15.9%) or less than that (6.8%).
The VAS intensity of the radiating pain was ranked by
71.7% of the patients as between 3 and 6/10. There were
8.7% who rated their pain as <3/10, and 17.4% rated the
pain as ≥7/10. Surgery for shooting pain was performed
in 4.3%. Pain control methods reported by 45.7% of
patients were: acetaminophen (17.4%), acetaminophen
and codeine combined (10.9%), ice (17.4%), and heat
(26.1%).
Chest pain
There were 30.4% who reported chest pain, and the
description of such pain varied widely: dull (48.1%),
stabbing (44.2%), intermittent (44.2%), aching (23.1%),
cramping (13.5%), and continuous (13.5%).
Frequency of chest symptoms ranged from constant
to less than once a month in the following distribu-
tion: constant (10%), daily (10%), once a week (28%),
once per month (22%), less than once per month
(30%).
Using a VAS, 57.7% of the patients reported the pain
to be between 2 to 4/10, while 30.8% reported it to
be between 5 to 7/10. Only 3.8% reported chest pain
with a VAS >7/10. Self-treatment approaches were as
follows: 28.8% of the patients reported taking medica-
tion for their chest pain, 1.9% used ice, and 7.7% used
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Fig. 8. Headache symptoms. Patients described their headaches using
multiple-choice options. The majority described it as pressure (57.8%),
although a large number also described it as throbbing (30.1%) or
pounding (28.9%). More than one type of presentation was noted in
many patients.
heat. Surgery for their chest pain was noted by 3.8% of
patients.
Headache
Chronic headaches were experienced by 48.5% of the
ADPKD group and the reported location was: frontal
(19.3%), whole head (13.3%), localized to one side
(12.0%). Figures 8 and 9 provide descriptions of the type
of headache pain and the frequency of occurrence.
A history of very severe headaches was reported
by 38% of respondents before the diagnosis of PKD.
Headaches were treated with medications by 32.7% of
this queried group. Only 1.2% of subjects reported having
surgery for their headaches (type of surgery and reason
not known).
Nausea alone associated with headaches was experi-
enced by 22.8%, and another 22.9% of patients noted ac-
companying vomiting. A head CT scan was performed in
11.1%, and 29.8% had a MRI/MRA of their head by the
time of the questionnaire. The investigation was precipi-
tated by the history of headaches. None of these patients
had evidence of an intracranial aneurysm.
Migraine attacks were self-reported in 13.5% of this
ADPKD cohort, but headaches were preceded by an aura
in only 6.4%. The most common time for a migraine was
split between morning and evening.
A history of CNS hemorrhage was reported by 1.8%. A
family history of CNS hemorrhage, stroke, or cerebrovas-
cular event was noted in 31% of those surveyed. After
the questionnaire, 40 patients of one of the authors (TIS)
underwent an MRA because of the reported headaches.
Not a single patient studied by radiologic imaging had any
evidence of intracranial aneurysm formation or other an-
giographic abnormalities.
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Fig. 9. Frequency of headache. There was a near equal distribution that
reported their headaches as occurring from daily to once per month.
Over one fourth of the patients had a rare headache.
DISCUSSION
Pain is a common feature in patients with ADPKD,
but the presentation of such pain, its severity, frequency,
and location have not been characterized in detail in the
literature. This is the first attempt to specifically document
the spectrum of pain in the afflicted population. Although
severe pain is a known event in patients with PKD, this
survey suggests that the frequency of pain is greater than
appreciated.
Noted is the frequency of self-medication in this pop-
ulation, and this finding indicates the physician needs to
question the patient about the use of pain medication that
can adversely affect kidney function (both prescription
and over-the-counter). It is known that patients may not
spontaneously report taking an over-the-counter medica-
tion because they consider only prescription medications
as drugs.
Results from the questionnaire in this PKD population
represent a self-reported overview about pain patterns.
Therefore, the limitations of self-reporting are evident,
especially after the individual knows their diagnosis of
PKD. In this survey there was almost a 16-year mean
hiatus between the diagnosis of PKD and the filling out
of the questionnaire. This prolonged time frame could
influence the exact accuracy and reporting of events.
Patients noted a multiplicity of complaints, and the
questionnaire may have unroofed a host of symptoms that
may or may not be related to the underlying diagnosis of
PKD. Also, this study was a point in time questionnaire,
and longitudinal follow-up is needed to characterize the
type and duration of pain so as to avoid generalities.
Analysis of the patients’ responses from the private
practice setting (one third of the respondents), which
included review of their lab data, leads to the observa-
tion that pain begins relatively early in the course of
ADPKD, often when kidney function is reported as “nor-
mal.” There is no apparent correlation between the level
of kidney function and the severity of pain. Simply stated,
pain is not a late event in the course of ADPKD.
Results reported are based on 171 full responders to
the questionnaire, and it cannot be stated if the approxi-
mate 130 nonresponders or partial responders represent
a group with different symptoms. With any questionnaire
survey, nonresponse tends to be a frequent occurrence.
There were only two subjects under age 18 who com-
pleted the questionnaire, so no statement can be made
about pain patterns in children or adolescents.
When asked, most patients with ADPKD were aware
of the familial nature of this disease (except for those
classified as spontaneous mutations). When patients in-
dicated a family history of the disease, it was present
in 70% of the time in a sibling. However, this aware-
ness of this queried population is not translated into
their correlating reported symptoms with the diagno-
sis of PKD. Almost 91% of respondents did not be-
lieve, or were not sure, that their symptoms were related
to PKD. Additional emphasis of this point is noted by
the frequent history of low back pain or abdominal
pain being recorded by 42% of patients before their di-
agnosis of PKD, and these symptoms did not lead to
the initial diagnosis. These results bespeak the need for
more patient education in the PKD population and their
families.
Gross hematuria led to the diagnosis in a relatively
small number of patients (16.4% of the total respon-
dents). Almost two thirds of the time the hematuria was
painless, and one third of the respondents noted it in asso-
ciation with back or abdominal pain. Therefore, assuming
that painful cyst rupture is the dominant cause for spon-
taneous gross hematuria does not appear to be true in
this population surveyed.
Causes of pain are multiple and can include conse-
quences directly related to cysts: cyst enlargement, cyst
rupture, and cyst infection [5, 9–16]. Severe back, flank,
and abdominal pain are known consequences of cyst en-
largement in patients with PKD. There is a wide variation
in perceived pain, and patients’ note a spectrum of symp-
toms. When examining symptoms associated with cysts,
one study looked at 19 single and combined symptoms in
400 patients. The only consistent and typical finding was
pain [17]. Pain localized to one side of the abdomen ex-
clusively can be related to renal asymmetry in ADPKD
[18].
Massive kidney and liver cysts commonly produce me-
chanical low back pain from exaggerated pelvic tilt and
subsequent lumbar lordosis. Subtle changes in posture oc-
cur slowly over time as cysts grow, with a forward thrust of
the abdomen from the enlarging cysts. Hence, mechanical
strain is placed on the lumbodorsal muscle group. Clini-
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cal presentation of chronic, aching low back pain and/or
sciatica should alert the physician to the etiology of the
discomfort in the patient with PKD. Approaches to the
treatment of PKD-associated mechanical back pain have
been reported [5].
This study found no correlation between the frequency
and severity of headaches and cerebral aneurysms. The
frequency and type of headaches was the same as in the
general population. Presence of hypertension was not
documented in this survey, so it is impossible to state if
blood pressure elevation played a role in the headache
constellation. As noted in the Results section, not one of
40 patients with a history of chronic headache, and no
family history of cerebral aneurysm, was found to have
any anatomic abnormality on cerebral MRA. Therefore,
in the absence of a family history of aneurysm forma-
tion, there appears to be no indication to order a brain
MRA based on a history alone of chronic headache in
the patient with PKD.
Generally, chest pain cannot be attributed directly to
PKD, so the noted incidence of chest pain in the re-
spondents cannot be explained. This is an observation
without noted clinical correlation. When patients start to
experience pain, more areas in the body can ache. How-
ever, there is the infrequent episode of thoracic aortic
aneurysm formation noted in the patient with PKD [19,
20]. Persistent mid-upper chest pain that does not repre-
sent anginal symptoms would warrant a chest x-ray.
In this questionnaire, 20.5% of patients reported that
no family member (i.e., grandparents, parents, aunts, un-
cles, siblings, cousins) was known to have PKD. Without a
negative ultrasound study in both parents, it is impossible
to state the true incidence of spontaneous mutations in
the PKD population. A negative ultrasound of both par-
ents reduces the probability of a diagnosis of ADPKD
to the level of a spontaneous mutation [21]. Therefore,
the true incidence of spontaneous mutation remains to
be determined.
One must also consider the rare possibility of ARPKD
being diagnosed in adulthood if there is a negative family
history for PKD and normal parental ultrasounds. The
presence of portal hypertension, related to hepatic fibro-
sis, in the patient with PKD points to the diagnosis of
ARPKD [21, 22].
Treatments
Appropriate diagnostic imaging [abdominal computed
tomography (CT), ultrasound, and magnetic resonance
imaging (MRI)] should follow the detailed history. The
combination of a specific pain history and radiologic
imaging should allow for a stepwise treatment algorithm.
A systematic approach to the management of pain in
patients with PKD has been well outlined [5]. Nonphar-
macologic therapy/physical measures, NSAIDS, COX-
2 inhibitors, Tramadol, autonomic plexus blockade, and
invasive procedures (spinal cord stimulation, neuraxial
opioids, and local anesthetics) should be employed in
a systematic approach to care. A care plan template is
needed before consideration of a surgical approach [5].
Some have used cyst aspiration to relieve the pain if
there are only a few cysts or a single dominant cyst [23].
Surgical cyst decompression (marsupialization/unroofing
of cysts) can provide effective relief of chronic pain with-
out improving or compromising renal function [24, 25].
Novel treatments have been attempted, includ-
ing laparoscopic renal denervation for intractable
ADPKD-related pain [abstract; Valente et al, Nephrol
Dial Transplant 16:160, 2001]. Classically, some of these
patients would have been scheduled for nephrectomy.
This new approach may allow a larger number of symp-
tomatic patients to benefit from minimally invasive
surgery.
CONCLUSION
Pain is the most frequent and prominent symptom lead-
ing to the diagnosis of PKD [2, 5, 8–17], and this survey
supports this observation. Patient documentation about
the frequency and severity of pain symptoms indicate that
a detailed history is mandatory if health care providers
are to approach the issues that impact patients’ lives.
Results from the questionnaire indicate the need for
the physician to be aware how PKD patients report pain.
Pain patterns are more diffuse and more frequent in the
patient with PKD than generally appreciated and may
not be reported spontaneously. It will not suffice for the
physician to hear the word “pain” and then immediately
reach for the prescription pad for an analgesic medica-
tion. There is the need for the physician to be vigilant
and perceptive when eliciting a history about pain issues
in their patients with PKD. Defining the etiology of the
pain pattern leads to a potential cascade of treatments,
many which are nonpharmacologic. An understanding of
the chronicity of the pain syndrome that can be disabling
and alter the quality of life will hopefully lead to specific
treatment approaches.
APPENDIX: The questionnaire employed in the PKD
Population
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